Skip to content

Effect of acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue to the electric potential on acupuncture points

Effect of acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue to the electric potential on acupuncture points

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0001864
Enrollment
40
Registered
2016-03-31
Start date
2014-03-31
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(acupuncture treatment) : The subjects in theraphy group were applied 10 times acupuncture treatment on GV20, GB20, BL11, BL13, BL15, BL18, BL20, BL23 for 4 weeks. The subjects in control group

Sponsors

Daejeon Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals presenting symptoms of continuous or repetitive fatigue of an unknown cause for at least 6 months. 2. Individuals without any abnormal findings in their blood pressure, general blood test (Hb, Hct, WBC, glucose), biochemical test (AST, ALT, Creatinine), electrolyte test (Na, K, Cl), thyroid function test (TSH: Thyroid Stimulating Hormone, FT_4: Free Thyroxine_4), pregnancy test (for fertile women), chest X-ray, and ECG; However, the criteria for abnormal findings were as follows: blood pressure was measured twice and averaged in a sitting position, with at least 2-minute intervals after resting at least for 5 minutes; systolic blood pressure of 160 mmHg and over or diastolic blood pressure of 100 mmHg and over; adult male Hb 13g/dL or less, Hct 38% or less, adult female(non-pregnant) Hb 11.5g/dL or less, Hct 36% or less, WBC 10,000/mm3 or over, random plasma glucose 200mg/dL or over, AST•ALT 100 IU/L or over, respectively, creatinine 1.5mg/dL or over, Na 135mmol/L or less or 145mmol/L or over, K 3.5mmol/L or less or 5.5mmol/L or over, Cl 97 mmol/L or less or 110 mmol/L or over, TSH 0.35mIU/mL or less or 5.50mIU/mL or over, FT4 0.89ng/dL or less or 1.76ng/dL or over, positive urinary hCG, tuberculosis lesions in the chest X-ray except inactive tuberculosis, arrhythmia in the ECG that needs treatment, heart diseases such as ischemic heart disease or cardiomegaly. 3. Individuals with NRS(Numeric Rating Scale) over 4 in the past week during the visit for screening. 4. Individuals who are clearly informed of the purpose and characteristics of the trial, agree to participate in it, and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals with the following causes of chronic fatigue in their past or current medical history: a. Organic causes: acute or chronic liver disease (hepatitis, cirrhosis), anemia, tuberculosis, chronic lung disease, cardiovascular disease (heart failure, hypertension), endocrinology/metabolic disorders (diabetes, hyperthyroidism or hypothyroidism, severe obesity with BMI over 45), autoimmune disease (rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis), malignant tumors, and infectious diseases. b. Psychosocial causes: depression, anxiety neurosis, recent severe stress, schizophrenia, alcoholism, eating disorders (anorexia, bulimia). 2. Individuals into whose body metal prostheses have been inserted to within 30cm of the electrode attachment spots. 3. Pregnant women, lactating women, or women planning pregnancy. 4. Individuals who are judged unable to maintain a supine position for at least for one hour. 5. Individuals who are unsuitable for acupuncture treatment due to systemic skin disorders or metal allergies. 6. Individuals who are currently participating in another clinical trial. 7. Individuals who have already experienced a hypersensitive reaction after acupuncture treatment. 8. Individuals currently residing in group facilities such as social welfare facilities. 9. Individuals who refuse to sign the consent form. 10. Individuals who are judged by the researchers to be unsuitable to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
bio-potential data

Secondary

MeasureTime frame
Fatigue Severity Scale;Numeric Rating Scale

Countries

Korea, Republic of

Contacts

Public ContactSeong Jin Cho

Korea Institute of Oriental Medicine

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026